CADL · Candel Therapeutics, Inc. · Analyst Estimates
$8.03
-0.35 (-4.18%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$614.44M
Shares
76.52M
Volume · Oct 23
1.18M
Avg daily vol (3M)
1.17M
Analyst Estimates
Compare analyst forecasts for Candel Therapeutics, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-10-23 02:33 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-1.28
|
-1.08
|
-0.74
|
3
|
-1.08
|
-1.00
|
-0.90
|
-0.87
|
1
|
1
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
0.00
|
0.00
|
0.00
|
8
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-1.47
|
-0.63
|
0.22
|
2
|
-0.63
|
-0.63
|
-0.61
|
0.22
|
0
|
0
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
0.00
|
41.92M
|
128.80M
|
9
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.33
|
-0.31
|
-0.29
|
2
|
-0.25
|
-0.25
|
-0.26
|
0.00
|
1
|
1
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
0.00
|
0.00
|
0.00
|
8
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.33
|
-0.33
|
-0.32
|
2
|
-0.31
|
-0.31
|
-0.31
|
0.00
|
1
|
1
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
0.00
|
0.00
|
0.00
|
8
|
— | — | — | — | — | — | — | — |
Key facts
CIK
1841387
CUSIP
137404109
13F (30d)
13 filings
13 filers
Visit website
Investor relations